One-Step Pharmaceutical Preparation of PEG-Modified Exosomes Encapsulating Anti-Cancer Drugs by a High-Pressure Homogenization Technique
Open Access
- 11 January 2023
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 16 (1) , 108
Abstract
The use of exosomes encapsulating therapeutic agents for the treatment of diseases is of increasing interest. However, some concerns such as limited efficiency and scalability of conventional drug encapsulation methods to exosomes have still remained; thus, a new approach that enables encapsulation of therapeutic agents with superior efficiency and scalability is required. Herein, we used RAW264 macrophage cell-derived exosomes (RAW-Exos) and demonstrated that high-pressure homogenization (HPH) using a microfluidizer decreased their particle size without changing their morphology, the amount of exosomal marker proteins, and cellular uptake efficiency into RAW264 and colon-26 cancer cells. Moreover, HPH allowed for modification of polyethylene glycol (PEG)-conjugated lipids onto RAW-Exos, as well as encapsulation of the anti-cancer agent doxorubicin. Importantly, the doxorubicin encapsulation efficiency became higher upon increasing the process pressure and simultaneous HPH with PEG-lipids. Moreover, treatment with PEG-modified RAW-Exos encapsulating doxorubicin significantly suppressed tumor growth in colon-26-bearing mice. Taken together, these results suggest that HPH using a microfluidizer could be useful to prepare PEG-modified Exos encapsulating anti-cancer drugs via a one-step pharmaceutical process, and that the prepared functional Exos could be applied for the treatment of cancer in vivo.Keywords
Funding Information
- Japan Society for the Promotion of Science (19K07169, 21K18065)
- Asahi Glass Foundation (19K07169, 21K18065)
This publication has 53 references indexed in Scilit:
- Amelioration of cerebral ischemia–reperfusion injury based on liposomal drug delivery system with asialo-erythropoietinJournal of Controlled Release, 2012
- Cryogenic transmission electron microscopy (cryo-TEM) for studying the morphology of colloidal drug delivery systemsInternational Journal of Pharmaceutics, 2011
- Production & stability of stavudine solid lipid nanoparticles—From lab to industrial scaleInternational Journal of Pharmaceutics, 2011
- Delivery of siRNA to the mouse brain by systemic injection of targeted exosomesNature Biotechnology, 2011
- Tumor delivery of macromolecular drugs based on the EPR effectAdvanced Drug Delivery Reviews, 2011
- A Novel Nanoparticle Drug Delivery System: The Anti-inflammatory Activity of Curcumin Is Enhanced When Encapsulated in ExosomesMolecular Therapy, 2010
- Pegylated Phospholipids-Based Self-Assembly with Water-Soluble DrugsPharmaceutical Research, 2009
- In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: Involvement of cytotoxic effect on vascular endothelial cellsJournal of Controlled Release, 2009
- Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipidGene Therapy, 2006
- The effect of alterations in fatty acid composition and cholesterol content on the nonelectrolyte permeability of Acholeplasma laidlawii B cells and derived liposomesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1973